An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Ghislaine A. van MastrigtDepartment of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands; Correspondence[email protected]

http://orcid.org/0000-0001-8053-5512

Silvia M. EversDepartment of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands; ;Department of Public Mental Healthcare, Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Center for Economic Evaluations, Utrecht, The Netherlands;

http://orcid.org/0000-0003-1026-570X

Marco HeeringsNational Multiple Sclerosis Foundation, Rotterdam, The Netherlands;

Leo H. VisserDepartment of Neurology, St. Elisabeth Hospital, Tilburg, The Netherlands; ;University of Humanistic Studies, Utrecht, The Netherlands;

Rob P. RuimschotelMedical Psychiatric Centre PsyToBe, Rotterdam, The Netherlands;

Astrid HussaartsNational Multiple Sclerosis Foundation, Rotterdam, The Netherlands;

Lotte DuyvermanMedical Psychiatric Centre PsyToBe, Rotterdam, The Netherlands;

Joyce Valkenburg-VissersFysiotherapie Maaspoort, 's-Hertogenbosch, The Netherlands;

Job CornelissenDansjobs, Landsmeer, The Netherlands;

Michel BosDepartment of Neurology, St. Anna Hospital, Geldrop, The Netherlands;

Maarten van DroffelaarNational Multiple Sclerosis Foundation, Rotterdam, The Netherlands;

Peter J. JongenDepartment of Community & Occupational Medicine, University Medical Centre Groningen, Groningen, The Netherlands; ;MS4 Research Institute, Nijmegen, The Netherlands

show all

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date